Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07K Hold
26
﹤0.01% 374
2026
Q1
$3.11K Hold
26
﹤0.01% 389
2025
Q4
$3.56K Hold
26
﹤0.01% 360
2025
Q3
$3.85K Hold
26
﹤0.01% 408
2025
Q2
$3.33K Hold
26
﹤0.01% 431
2025
Q1
$2.89K Hold
26
﹤0.01% 424
2024
Q4
$3.02K Sell
26
-250
-91% -$31.6K ﹤0.01% 408
2024
Q3
$37.3K Hold
276
0.02% 233
2024
Q2
$36.6K Buy
276
+26
+10% +$3.54K 0.02% 239
2024
Q1
$31.9K Hold
250
0.01% 257
2023
Q4
$26.4K Hold
250
0.01% 270
2023
Q3
$22.5K Buy
+250
New +$25.8K 0.01% 270

Other funds holding XYL

Pacifica Partners's XYL Position: Q2 2026 in Review

Pacifica Partners held its Xylem (XYL) position steady in Q2 2026 at 26 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #374.

Pacifica Partners first reported a position in XYL in Q3 2023 and has held it in 12 quarters since. The position peaked at $37.3K in Q3 2024. 274 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Pacifica Partners held 26 shares of Xylem worth $3.07K as of Q2 2026.
  • Pacifica Partners left its Xylem share count unchanged in Q2 2026.
  • Xylem made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #374 holding.
  • Pacifica Partners first reported a position in Xylem in Q3 2023 and has held it in 12 quarters since.
  • Pacifica Partners's Xylem position peaked at $37.3K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.